These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 21777827)
1. The monoamine neurotransmitter disorders: an expanding range of neurological syndromes. Kurian MA; Gissen P; Smith M; Heales S; Clayton PT Lancet Neurol; 2011 Aug; 10(8):721-33. PubMed ID: 21777827 [TBL] [Abstract][Full Text] [Related]
2. Monoamine neurotransmitter disorders--clinical advances and future perspectives. Ng J; Papandreou A; Heales SJ; Kurian MA Nat Rev Neurol; 2015 Oct; 11(10):567-84. PubMed ID: 26392380 [TBL] [Abstract][Full Text] [Related]
3. Clinical features and pharmacotherapy of childhood monoamine neurotransmitter disorders. Ng J; Heales SJ; Kurian MA Paediatr Drugs; 2014 Aug; 16(4):275-91. PubMed ID: 25011953 [TBL] [Abstract][Full Text] [Related]
4. What is new for monoamine neurotransmitter disorders? Marecos C; Ng J; Kurian MA J Inherit Metab Dis; 2014 Jul; 37(4):619-26. PubMed ID: 24696406 [TBL] [Abstract][Full Text] [Related]
6. Inherited Disorders of Neurotransmitters: Classification and Practical Approaches for Diagnosis and Treatment. Brennenstuhl H; Jung-Klawitter S; Assmann B; Opladen T Neuropediatrics; 2019 Feb; 50(1):2-14. PubMed ID: 30372766 [TBL] [Abstract][Full Text] [Related]
7. Monoamine modulation of tonic GABAA inhibition. Crunelli V; Di Giovanni G Rev Neurosci; 2014; 25(2):195-206. PubMed ID: 24468610 [TBL] [Abstract][Full Text] [Related]
8. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex. Rollema H; Wilson GG; Lee TC; Folgering JH; Flik G Neurochem Int; 2011 Jan; 58(1):78-84. PubMed ID: 21056607 [TBL] [Abstract][Full Text] [Related]
9. Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters. Vaughan RA J Pharmacol Exp Ther; 2004 Jul; 310(1):1-7. PubMed ID: 15064332 [TBL] [Abstract][Full Text] [Related]
12. Ancestry of neuronal monoamine transporters in the Metazoa. Caveney S; Cladman W; Verellen L; Donly C J Exp Biol; 2006 Dec; 209(Pt 24):4858-68. PubMed ID: 17142674 [TBL] [Abstract][Full Text] [Related]
13. Clinical utility of monoamine neurotransmitter metabolite analysis in cerebrospinal fluid. Hyland K Clin Chem; 2008 Apr; 54(4):633-41. PubMed ID: 18310141 [TBL] [Abstract][Full Text] [Related]
14. Neuroimaging Spectrum of Inherited Neurotransmitter Disorders. Lim YT; Mankad K; Kinali M; Tan AP Neuropediatrics; 2020 Feb; 51(1):6-21. PubMed ID: 31634934 [TBL] [Abstract][Full Text] [Related]
15. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system. Hoffman BJ; Hansson SR; Mezey E; Palkovits M Front Neuroendocrinol; 1998 Jul; 19(3):187-231. PubMed ID: 9665836 [TBL] [Abstract][Full Text] [Related]
16. Monoamine neurotransmitters and movement disorders in children and adults. Doummar D; Moussa F; Nougues MC; Ravelli C; Louha M; Whalen S; Burglen L; Rodriguez D; Billette de Villemeur T Rev Neurol (Paris); 2018 Nov; 174(9):581-588. PubMed ID: 30166070 [TBL] [Abstract][Full Text] [Related]
17. [Regulatory role of monoamine neurotransmitters in Saccharomyces cerevisiae cells]. Malikina KD; Shishov VA; Chuvelev DI; Kudrin VS; Oleskin AV Prikl Biokhim Mikrobiol; 2010; 46(6):672-7. PubMed ID: 21261078 [TBL] [Abstract][Full Text] [Related]
18. [Changes in brain monoamine neurotransmitter in iron deficiency nonanemic rats]. Hu R; Wei M; Ding X Zhonghua Yu Fang Yi Xue Za Zhi; 1996 Nov; 30(6):351-3. PubMed ID: 9388911 [TBL] [Abstract][Full Text] [Related]
19. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Hoffmann GF; Assmann B; Bräutigam C; Dionisi-Vici C; Häussler M; de Klerk JB; Naumann M; Steenbergen-Spanjers GC; Strassburg HM; Wevers RA Ann Neurol; 2003; 54 Suppl 6():S56-65. PubMed ID: 12891655 [TBL] [Abstract][Full Text] [Related]